12 min

Ep. 06 – Tirzepatide como tendência no tratamento para DM2‪.‬ Journal Club Endoped ICr-USP

    • Medicine

Dual GIP and GLP-1 Receptor Agonist - Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes. 

(DOI: https://doi.org/10.1210/clinem/dgaa863)

  • EndocrinoICr

Dual GIP and GLP-1 Receptor Agonist - Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes. 

(DOI: https://doi.org/10.1210/clinem/dgaa863)

12 min

  • EndocrinoICr